Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry. 2009

Sameer K Mehta, and Andrew D Frutkin, and Jason B Lindsey, and John A House, and John A Spertus, and Sunil V Rao, and Fang-Shu Ou, and Matthew T Roe, and Eric D Peterson, and Steven P Marso, and
Division of Cardiovascular Research, Mid America Heart Institute, Saint Luke's Hospital, Kansas City, MO 64111, USA.

BACKGROUND Bleeding in patients undergoing percutaneous coronary intervention (PCI) is associated with increased morbidity, mortality, length of hospitalization, and cost. We identified baseline clinical characteristics associated with bleeding complications after PCI and developed a simplified, clinically useful algorithm to predict patient risk. RESULTS Data were analyzed from 302 152 PCI procedures performed at 440 US centers participating in the National Cardiovascular Data Registry. As defined by the National Cardiovascular Data Registry, bleeding required transfusion, prolonged hospital stay, and/or a drop in hemoglobin >3.0 g/dL from any location, including percutaneous entry site, retroperitoneal, gastrointestinal, genitourinary, and other/unknown location. Bleeding complications occurred in 2.4% of patients. From the best-fitting model consisting of 15 clinical elements associated with post-PCI bleeding in a random 80% training cohort, we developed a parsimonious risk algorithm. Predictors of bleeding included age, gender, previous heart failure, glomerular filtration rate, peripheral vascular disease, no previous PCI, New York Heart Association/Canadian Cardiovascular Society Functional Classification class IV heart failure, ST-elevation myocardial infarction, non-ST-elevation myocardial infarction, and cardiogenic shock. The parsimonious model was validated in the remaining 20% of the population (c-statistic, 0.72) and in clinically relevant subgroups of patients. This simplified model was used to derive a clinical risk algorithm, with larger numbers corresponding with greater risk. In 3 categories, bleeding rates were greater in patients with higher estimates (<or=7, 0.7%; 8 to 17, 1.8%; >or=18, 5.1%). CONCLUSIONS This report identifies baseline clinical factors associated with bleeding and proposes a clinically useful algorithm to estimate bleeding risk. This model is potentially actionable in altering therapeutic decision making and improving outcomes in patients undergoing PCI.

UI MeSH Term Description Entries
D007902 Length of Stay The period of confinement of a patient to a hospital or other health facility. Hospital Stay,Hospital Stays,Stay Length,Stay Lengths,Stay, Hospital,Stays, Hospital
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010975 Platelet Aggregation Inhibitors Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. Antiaggregants, Platelet,Antiplatelet Agent,Antiplatelet Agents,Antiplatelet Drug,Blood Platelet Aggregation Inhibitor,Blood Platelet Antagonist,Blood Platelet Antiaggregant,PAR-1 Antagonists,Platelet Aggregation Inhibitor,Platelet Antagonist,Platelet Antagonists,Platelet Antiaggregant,Platelet Antiaggregants,Platelet Inhibitor,Protease-Activated Receptor-1 Antagonists,Antiplatelet Drugs,Blood Platelet Aggregation Inhibitors,Blood Platelet Antagonists,Blood Platelet Antiaggregants,Platelet Inhibitors,Agent, Antiplatelet,Aggregation Inhibitor, Platelet,Antagonist, Blood Platelet,Antagonist, Platelet,Antiaggregant, Blood Platelet,Antiaggregant, Platelet,Drug, Antiplatelet,Inhibitor, Platelet,Inhibitor, Platelet Aggregation,PAR 1 Antagonists,Platelet Antagonist, Blood,Platelet Antiaggregant, Blood,Protease Activated Receptor 1 Antagonists
D012042 Registries The systems and processes involved in the establishment, support, management, and operation of registers, e.g., disease registers. Parish Registers,Population Register,Parish Register,Population Registers,Register, Parish,Register, Population,Registers, Parish,Registers, Population,Registry
D001803 Blood Transfusion The introduction of whole blood or blood component directly into the blood stream. (Dorland, 27th ed) Blood Transfusions,Transfusion, Blood,Transfusions, Blood
D003661 Decision Support Techniques Mathematical or statistical procedures used as aids in making a decision. They are frequently used in medical decision-making. Decision Analysis,Decision Modeling,Models, Decision Support,Analysis, Decision,Decision Aids,Decision Support Technics,Aid, Decision,Aids, Decision,Analyses, Decision,Decision Aid,Decision Analyses,Decision Support Model,Decision Support Models,Decision Support Technic,Decision Support Technique,Model, Decision Support,Modeling, Decision,Technic, Decision Support,Technics, Decision Support,Technique, Decision Support,Techniques, Decision Support
D005260 Female Females
D006454 Hemoglobins The oxygen-carrying proteins of ERYTHROCYTES. They are found in all vertebrates and some invertebrates. The number of globin subunits in the hemoglobin quaternary structure differs between species. Structures range from monomeric to a variety of multimeric arrangements. Eryhem,Ferrous Hemoglobin,Hemoglobin,Hemoglobin, Ferrous
D006470 Hemorrhage Bleeding or escape of blood from a vessel. Bleeding,Hemorrhages

Related Publications

Sameer K Mehta, and Andrew D Frutkin, and Jason B Lindsey, and John A House, and John A Spertus, and Sunil V Rao, and Fang-Shu Ou, and Matthew T Roe, and Eric D Peterson, and Steven P Marso, and
September 2015, Circulation,
Sameer K Mehta, and Andrew D Frutkin, and Jason B Lindsey, and John A House, and John A Spertus, and Sunil V Rao, and Fang-Shu Ou, and Matthew T Roe, and Eric D Peterson, and Steven P Marso, and
September 2013, JACC. Cardiovascular interventions,
Sameer K Mehta, and Andrew D Frutkin, and Jason B Lindsey, and John A House, and John A Spertus, and Sunil V Rao, and Fang-Shu Ou, and Matthew T Roe, and Eric D Peterson, and Steven P Marso, and
May 2012, Journal of the American College of Cardiology,
Sameer K Mehta, and Andrew D Frutkin, and Jason B Lindsey, and John A House, and John A Spertus, and Sunil V Rao, and Fang-Shu Ou, and Matthew T Roe, and Eric D Peterson, and Steven P Marso, and
March 2016, Circulation. Cardiovascular interventions,
Sameer K Mehta, and Andrew D Frutkin, and Jason B Lindsey, and John A House, and John A Spertus, and Sunil V Rao, and Fang-Shu Ou, and Matthew T Roe, and Eric D Peterson, and Steven P Marso, and
February 2021, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology,
Sameer K Mehta, and Andrew D Frutkin, and Jason B Lindsey, and John A House, and John A Spertus, and Sunil V Rao, and Fang-Shu Ou, and Matthew T Roe, and Eric D Peterson, and Steven P Marso, and
January 2012, Circulation. Cardiovascular quality and outcomes,
Sameer K Mehta, and Andrew D Frutkin, and Jason B Lindsey, and John A House, and John A Spertus, and Sunil V Rao, and Fang-Shu Ou, and Matthew T Roe, and Eric D Peterson, and Steven P Marso, and
November 2018, Coronary artery disease,
Sameer K Mehta, and Andrew D Frutkin, and Jason B Lindsey, and John A House, and John A Spertus, and Sunil V Rao, and Fang-Shu Ou, and Matthew T Roe, and Eric D Peterson, and Steven P Marso, and
October 2019, American heart journal,
Sameer K Mehta, and Andrew D Frutkin, and Jason B Lindsey, and John A House, and John A Spertus, and Sunil V Rao, and Fang-Shu Ou, and Matthew T Roe, and Eric D Peterson, and Steven P Marso, and
February 2018, Circulation. Cardiovascular interventions,
Sameer K Mehta, and Andrew D Frutkin, and Jason B Lindsey, and John A House, and John A Spertus, and Sunil V Rao, and Fang-Shu Ou, and Matthew T Roe, and Eric D Peterson, and Steven P Marso, and
May 2010, Journal of the American College of Cardiology,
Copied contents to your clipboard!